Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Tesar

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Annals of the Rheumatic Diseases|August 21, 2008
Deoxyspergualin in relapsing and refractory Wegener's granulomatosisO Flossmann, B Baslund, A Bruchfeld, et al.
Physiological Research|December 14, 2004
Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic ratsM Opocenský, P Dvorák, J Malý, et al.
Journal of Nephrology|December 31, 2020
Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injuryN Steiner, A Abdel Hamid, A Kronbichler, et al.
Lupus|July 8, 2010
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune studyJ Zavada, Ss Pesickova, R Rysava, et al.
Lupus|November 12, 2013
Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine AJ Závada, S Sinikka Pesicková, R Rysavá, et al.
Annals of the Rheumatic Diseases|June 25, 2016
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitisM Yates, R A Watts, I M Bajema, et al.
Clinical and Experimental Rheumatology|May 29, 2015
Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohortsC Pagnoux, S Carette, N A Khalidi, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Annals of the Rheumatic Diseases|August 21, 2008
Deoxyspergualin in relapsing and refractory Wegener's granulomatosisO Flossmann, B Baslund, A Bruchfeld, et al.
Physiological Research|December 14, 2004
Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic ratsM Opocenský, P Dvorák, J Malý, et al.
Journal of Nephrology|December 31, 2020
Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injuryN Steiner, A Abdel Hamid, A Kronbichler, et al.
Lupus|July 8, 2010
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune studyJ Zavada, Ss Pesickova, R Rysava, et al.
Lupus|November 12, 2013
Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine AJ Závada, S Sinikka Pesicková, R Rysavá, et al.
Annals of the Rheumatic Diseases|June 25, 2016
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitisM Yates, R A Watts, I M Bajema, et al.
Clinical and Experimental Rheumatology|May 29, 2015
Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohortsC Pagnoux, S Carette, N A Khalidi, et al.
Pageof 19